ATE408145T1 - Verfahren zum nachweis von nierenkrankheiten und zur pathologischen überwachung - Google Patents
Verfahren zum nachweis von nierenkrankheiten und zur pathologischen überwachungInfo
- Publication number
- ATE408145T1 ATE408145T1 AT99940663T AT99940663T ATE408145T1 AT E408145 T1 ATE408145 T1 AT E408145T1 AT 99940663 T AT99940663 T AT 99940663T AT 99940663 T AT99940663 T AT 99940663T AT E408145 T1 ATE408145 T1 AT E408145T1
- Authority
- AT
- Austria
- Prior art keywords
- synthase
- concentration
- subject
- determining
- body fluid
- Prior art date
Links
- 208000017169 kidney disease Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000012544 monitoring process Methods 0.000 title 1
- 230000001575 pathological effect Effects 0.000 title 1
- 101001135402 Homo sapiens Prostaglandin-H2 D-isomerase Proteins 0.000 abstract 3
- 210000001124 body fluid Anatomy 0.000 abstract 3
- 239000010839 body fluid Substances 0.000 abstract 3
- 238000001514 detection method Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000024924 glomerular filtration Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25145098 | 1998-09-04 | ||
| JP13305099A JP3961152B2 (ja) | 1998-09-04 | 1999-05-13 | 腎疾患の検出および病態管理方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE408145T1 true ATE408145T1 (de) | 2008-09-15 |
Family
ID=26467489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99940663T ATE408145T1 (de) | 1998-09-04 | 1999-09-03 | Verfahren zum nachweis von nierenkrankheiten und zur pathologischen überwachung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7109044B1 (de) |
| EP (1) | EP1111387B1 (de) |
| JP (1) | JP3961152B2 (de) |
| KR (1) | KR100705732B1 (de) |
| AT (1) | ATE408145T1 (de) |
| AU (1) | AU750574B2 (de) |
| CA (1) | CA2342897A1 (de) |
| DE (1) | DE69939544D1 (de) |
| WO (1) | WO2000014543A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0217402D0 (en) * | 2002-07-26 | 2002-09-04 | Roslin Inst Edinburgh | Multi-reporter gene model for toxicological screening |
| EP1535077A2 (de) * | 2002-08-29 | 2005-06-01 | University Of Florida Research Foundation, Inc. | Cox-2 vermittelte veränderte prostaglandin-balance bei diabetes-komplikationen |
| JP2004108914A (ja) * | 2002-09-18 | 2004-04-08 | Kudo Norio | コラーゲンの測定方法 |
| JP3897117B2 (ja) * | 2003-09-24 | 2007-03-22 | マルハ株式会社 | 妊娠中毒症の重症度判定と予知方法、および妊娠中毒症における胎児・胎盤機能の評価方法 |
| US20080233597A1 (en) * | 2003-09-26 | 2008-09-25 | Yasuhiko Shiina | Method of Detecting or Differentiating Rheumatoid Arthritis and Method of Determining Stage of Disease or Degree of Dysfunction with Regard to Rheumatoid Arthritis |
| JP4871173B2 (ja) * | 2007-03-06 | 2012-02-08 | 三菱化学メディエンス株式会社 | 糖尿病性腎症患者の病態把握方法 |
| EP2153234A2 (de) * | 2007-05-11 | 2010-02-17 | The Institutes for Pharmaceutical Discovery, LLC | Verfahren zur frühdiagnose einer nierenerkrankung |
| WO2011027573A1 (ja) * | 2009-09-04 | 2011-03-10 | 国立大学法人東北大学 | ヒトにおける新たな腎疾患マーカー物質 |
| DE102012018076B4 (de) | 2012-09-13 | 2014-06-12 | Lohmann Gmbh & Co. Kg | Klebender Funktionsstreifen zur transkutanen Fluoreszenzmessung sowie zugehörige Herstellungsverfahren und Verwendungen |
| WO2014066568A1 (en) | 2012-10-24 | 2014-05-01 | Winthrop-University Hospital | Non-invasive biomarker to identify subjects at risk of preterm delivery |
| JP5841644B2 (ja) * | 2014-07-30 | 2016-01-13 | シスメックス株式会社 | 尿検査方法および尿検査装置 |
| CA3075688A1 (en) | 2017-09-13 | 2019-03-21 | Progenity, Inc. | Preeclampsia biomarkers and related systems and methods |
| CN108918571B (zh) * | 2018-06-15 | 2021-02-02 | 山西大学 | 代谢标志物在制备肾病综合征病变进程诊断鉴别试剂中的应用 |
| EP4070113A4 (de) | 2019-12-04 | 2023-12-20 | Biora Therapeutics, Inc. | Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6122540A (en) * | 1994-06-08 | 2000-09-19 | The Regents Of The University Of California | Noninvasive measurement of renal hemodynamic functions using magnetic resonance imaging |
| ATE315048T1 (de) | 1995-10-31 | 2006-02-15 | Maruha Corp | Monoklonaler antikoerper spezifisch fuer prostaglandin d synthetase |
-
1999
- 1999-04-09 US US09/786,503 patent/US7109044B1/en not_active Expired - Fee Related
- 1999-05-13 JP JP13305099A patent/JP3961152B2/ja not_active Expired - Fee Related
- 1999-09-03 AU AU54491/99A patent/AU750574B2/en not_active Ceased
- 1999-09-03 EP EP99940663A patent/EP1111387B1/de not_active Expired - Lifetime
- 1999-09-03 DE DE69939544T patent/DE69939544D1/de not_active Expired - Lifetime
- 1999-09-03 KR KR1020017003020A patent/KR100705732B1/ko not_active IP Right Cessation
- 1999-09-03 CA CA002342897A patent/CA2342897A1/en not_active Abandoned
- 1999-09-03 AT AT99940663T patent/ATE408145T1/de not_active IP Right Cessation
- 1999-09-03 WO PCT/JP1999/004804 patent/WO2000014543A1/ja active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP1111387A1 (de) | 2001-06-27 |
| AU5449199A (en) | 2000-03-27 |
| JP2000146980A (ja) | 2000-05-26 |
| US7109044B1 (en) | 2006-09-19 |
| EP1111387A4 (de) | 2002-08-21 |
| JP3961152B2 (ja) | 2007-08-22 |
| DE69939544D1 (de) | 2008-10-23 |
| AU750574B2 (en) | 2002-07-25 |
| KR100705732B1 (ko) | 2007-04-09 |
| KR20010078380A (ko) | 2001-08-20 |
| CA2342897A1 (en) | 2000-03-16 |
| WO2000014543A1 (fr) | 2000-03-16 |
| EP1111387B1 (de) | 2008-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE408145T1 (de) | Verfahren zum nachweis von nierenkrankheiten und zur pathologischen überwachung | |
| DE60132033D1 (de) | Vorrichtung zur segmentären Bioimpedanzmessung von einem Dialysepatienten | |
| ATE475876T1 (de) | Diagnostischer teststreifen zum sammeln und bestimmen eines analyts in einer fluiden probe und verfahren zur verwendung desselben | |
| DK1570274T3 (da) | Analysator og analysefremgangsmåde og en væskekassette | |
| ATE406834T1 (de) | System zur überwachung der konzentration von analyten in körperflüssigkeiten | |
| DE50111644D1 (de) | Verfahren und vorrichtung zum nachweisen von substanzen in körperflüssigkeiten mittels raman-spektroskopie | |
| DE69910003D1 (de) | Überwachung physiologischer analyte | |
| DK1342794T3 (da) | Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker | |
| DE60218268D1 (de) | Verfahren zur Analyse der Blutkoagluationsreaktion | |
| DE69632998D1 (de) | Hochempfindliches, genaues und präzises automatisiertes Messverfahren und Vorrichtung zur Identifizierung und Quantifizierung von Blutplättchen und zur Bestimmung des Blutplättchenaktivitätszustands unter Verwendung von Ganzblutproben | |
| DE69901743T2 (de) | Biosensor, iontophoretischen Probenahmesystem, und Verfahren zur seiner Anwendung | |
| DE69917258D1 (de) | Methode und vorrichtung zum elektrochemischen immunoassay mehrerer analyten | |
| NO20050186L (no) | Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser | |
| WO2005112742A3 (en) | Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same | |
| ATE360090T1 (de) | Vorrichtung und verfahren zum bestimmen der koagulation in flüssigproben | |
| DE60315715D1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| WO2000026668A3 (en) | S100 proteins and autoantibodies as serum markers for cancer | |
| ATE314648T1 (de) | Diagnostisches verfahren für asthma | |
| DE60112949D1 (de) | Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes | |
| ATE410695T1 (de) | Screening-verfahren für den prädiabetiszustand und screening-reagenz | |
| FR2805545B1 (fr) | Procede electrochimique de detection d'acides nucleiques | |
| DE69708102T2 (de) | Verfahren und reagenz zur überwachung des blutspiegels von antiplättchen-verbindungen | |
| US11629387B1 (en) | Methods and devices for COVID-19 testing using urine samples | |
| JP2009204465A (ja) | 銀染色を用いる電気泳動法により腎疾患等の病態を判定する方法 | |
| DE60102245D1 (de) | Anhand der konduktivität normalisierte bestimmung von analyten in urin zur diagnose von krankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |